logo-loader
viewErgomed PLC

Ergomed reveals it is providing clinical research services for a study in Italy for the treatment of patients with coronavirus

The group noted that the study is sponsored by the Papa Giovanni XXIII Hospital in Bergamo, Italy and supported by EUSA Pharma (EUSA)

Ergomed PLC -
In early morning trading, Ergomed shares were 11.4% higher at 312p

Ergomed PLC (LON:ERGO) shares jumped on Wednesday as the firm revealed it is providing clinical research services for a study in Italy for the treatment of patients with coronavirus (COVID-19).

In a statement, the AIM-listed company which is focused on providing specialised services to the pharmaceutical industry, today announced the initiation of a study of siltuximab, an interleukin (IL)-6 targeted monoclonal antibody, for the treatment of patients with COVID-19 who have developed serious respiratory complications.

READ: Ergomed's underlying earnings set to top expectations after a strong year

The group noted that the study is sponsored by the Papa Giovanni XXIII Hospital in Bergamo, Italy and supported by EUSA Pharma (EUSA).

Ergomed said it is providing clinical research services for the study and has been integrally involved in the design and implementation of the study from a clinical and operational perspective.

Dr Miroslav Reljanović, Ergomed’s executive chairman commented: "COVID-19 represents an unprecedented global healthcare challenge and the rapid evaluation of therapies which could alter the course of the infection and improve outcomes for patients is vital.

“Ergomed is proud to be making a contribution to this effort by bringing our proven capabilities and expertise to bear on this important study."

In early morning trading, Ergomed shares were 11.4% higher at 312p.

Quick facts: Ergomed PLC

Price: 405 GBX

AIM:ERGO
Market: AIM
Market Cap: £187.81 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ergomed PLC named herein, including the promotion by the Company of Ergomed PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: Easyjet grounds entire fleet of aircraft; Loganair asks for...

Headlines from the Proactive UK newsroom. Easyjet has grounded its entire fleet of aircraft due to the lockdowns caused by the coronavirus outbreak. Its last rescue flight landed yesterday. Another regional carrier, Loganair, has asked the government for financial help to survive the...

2 hours, 2 minutes ago

2 min read